NCI SBIR & STTR: Advancing the Commercialization of New Cancer Innovations
Twice as many people survived cancer in 2012 than did in 1992. Today, the National Cancer Institute (NCI) is poised to further accelerate the rate of scientific discovery and reduce the burden of cancer in the United States and around the world.

Michael Weingarten, Director for the NCI SBIR Development Center, Andrew Kurtz, Program Director & Team Leader with the NCI SBIR Development Center, and Todd Haim, Program Director with the NCI SBIR Development Center will present and discuss the SBIR and STTR programs that fund and support small biomedical technology companies. These representatives will cover:

• NIH/NCI SBIR Overview and Initiatives, as well as eligibility requirements
• NIH SBIR/STTR process and new cancer-focused grant funding opportunities from NCI
• New NCI SBIR/STTR initiatives such as NIH Innovation Corps (I-Corps™) Team Training Pilot Program
• NCI efforts to help NCI SBIR-funded companies to connect with investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries
• Practical strategies on how to successfully submit competitive research proposals

Following the presentation and Q&A, don\’t miss this opportunity to introduce yourself to the NCI SBIR Development Center representatives during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with will provide a forum to further discuss your company with the NCI.

Don\’t miss the opportunity to meet one-on-one with directors from the NCI SBIR Development Center: apply today!.

Agenda:
9:00am | Registration Opens
9:30am | Presentation: NIH/NCI SBIR Overview and Initiatives
10:30am | Presentation: Tips on Submitting Competitive Applications
11:15am | Networking Lunch
12:00-2:00pm | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends July 20, 2015. APPLY HERE

National Cancer Institute Participating Representatives:
Todd Haim | Program Director, SBIR Development Center, National Cancer Institute read bio»
Andrew Kurtz | Program Director & Team Leader, SBIR Development Center, National Cancer Institute read bio»
Michael Weingarten | Director, SBIR Development Center, National Cancer Institute read bio»

About the National Cancer Institute:
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government\’s principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice. The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Fees:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until August 5th or sold out.

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period will close on July 20, 2015. Your application will be reviewed and you will be notified of acceptance on July 31, 2015. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

Venue:
JLABS @LabCentral
700 Main Street
Cambridge, MA 02139